{"title":"COVID-19大流行期间及未来SARS-CoV-2疫苗研制进展","authors":"Chrysanthus Chukwuma Sr","doi":"10.47363/pms/2022(6)172","DOIUrl":null,"url":null,"abstract":"SARS-CoV-2, the etiologic agent of the COVID-19 pandemic, spatiotemporally evolves or mutates to its variant with potentialities for adverse opportunistic infections via replications and transmissions or disseminations","PeriodicalId":121507,"journal":{"name":"Progress in Medical Sciences","volume":"31 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Progress in the Ascertainment of Vaccines Regarding SARS-CoV-2 During the COVID-19 Pandemic and in the Future\",\"authors\":\"Chrysanthus Chukwuma Sr\",\"doi\":\"10.47363/pms/2022(6)172\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"SARS-CoV-2, the etiologic agent of the COVID-19 pandemic, spatiotemporally evolves or mutates to its variant with potentialities for adverse opportunistic infections via replications and transmissions or disseminations\",\"PeriodicalId\":121507,\"journal\":{\"name\":\"Progress in Medical Sciences\",\"volume\":\"31 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Progress in Medical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47363/pms/2022(6)172\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47363/pms/2022(6)172","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Progress in the Ascertainment of Vaccines Regarding SARS-CoV-2 During the COVID-19 Pandemic and in the Future
SARS-CoV-2, the etiologic agent of the COVID-19 pandemic, spatiotemporally evolves or mutates to its variant with potentialities for adverse opportunistic infections via replications and transmissions or disseminations
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
